CoChat

Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art

Open access

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Abstract

Acute myocarditis (AM) is an inflammatory cardiac condition resulting from infections, toxic exposures, or immune-mediated mechanisms, with clinical presentations ranging from mild symptoms to heart failure (HF) or cardiogenic shock. Although viral infections remain the predominant cause, both the absolute prevalence and the relative distribution of different etiologies may change over time and across regions depending on endemic diseases. Immune checkpoint inhibitor (ICI)-associated myocarditis has emerged as a newly recognized entity, with diagnostic rates increasing in parallel with growing awareness and the expanding population of cancer patients eligible for ICI therapy. Additionally, genetic predisposition—particularly mutations linked to arrhythmogenic cardiomyopathy—is also being increasingly acknowledged as a susceptibility factor. Recent advances have markedly improved the diagnostic approach to AM. The availability of high-sensitivity cardiac troponins and the widespread use of cardiac magnetic resonance imaging (CMRI) have enhanced early detection and tissue characterization. CMRI, especially following the updated Lake Louise Criteria (2018), which incorporate T1 and T2 mapping, enables accurate assessment of myocardial inflammation and fibrosis. Endomyocardial biopsy (EMB) remains essential in complicated cases, particularly to identify histologic subtypes that may benefit from immunosuppressive therapy. Early EMB (within 48 h) has been associated with better outcomes in fulminant presentations. The use of immunohistochemistry with leukocyte-specific markers has further increased the sensitivity of EMB. Therapeutic strategies now integrate etiology-specific approaches. Immunosuppressive therapy is indicated for distinct histological forms such as eosinophilic (EM) and giant cell myocarditis (GCM) or cases associated with systemic autoimmune disease. Conversely, in most patients with acute myocarditis complicated by acute HF or cardiogenic shock, no specific treatment is currently recommended beyond evidence-based management of acute HF and general supportive therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm14217661

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cardiac magnetic resonance findings. Acute non-ischaemic myocardial injury at mid to apical septal, anterior, and anterolateral walls. (A) Increased native T1 values (up to 1260 ms); (B) increased T2 values (up to 71 ms); (C) increased signal intensity at T2-weighted images; and (D) nonischaemic late gadolinium enhancement. All abnormal findings have matched subepicardial distribution (white arrows). Reproduced with permission from ref. [81].
Figure 1 Cardiac magnetic resonance findings. Acute non-ischaemic myocardial injury at mid to apical septal, anterior, and anterolateral walls. (A) Increased native T1 values (up to 1260 ms); (B) increased T2 values (up to 71 ms); (C) increased signal intensity at T2-weighted images; and (D) nonischaemic late gadolinium enhancement. All abnormal findings have matched subepicardial distribution (white arrows). Reproduced with permission from ref. [81].CC BY · PubMed Central
Figure 2 Electro-anatomic mapping and endomyocardial biopsy. Electro-anatomical voltage mapping of the left ventricle. The bipolar mapping is mainly normal (purple); low-voltage area (red) is noted in the inferolateral basal wall.
Figure 2 Electro-anatomic mapping and endomyocardial biopsy. Electro-anatomical voltage mapping of the left ventricle. The bipolar mapping is mainly normal (purple); low-voltage area (red) is noted in the inferolateral basal wall.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Cited by

See all 8

Metadata

Authors
Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C.
Affiliations
  • Centro Cardiologico Monzino (IT)
  • University of Insubria (IT)
  • University of Milan (IT)
Corresponding author
Vignati, Carlo
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2025-10-28
Volume
14
Issue
21
Pages
7661
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4415683551
Cited by
6
References
107
Citations by year
2026: 6
FWCI
1.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Takotsubo Cardiomyopathy and Associated Phenomena
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
Keywords
acute myocarditis, immune checkpoint inhibitor-associated myocarditis, viral myocarditis, arrhythmogenic cardiomyopathy, endomyocardial biopsy, cardiac magnetic resonance imaging, Lake Louise criteria, high-sensitivity troponin, immunosuppressive therapy, eosinophilic myocarditis, giant cell myocarditis, heart failure, cardiogenic shock

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art. https://app.cochat.ai/papers/10.3390/jcm14217661
The paper
Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C. (2025). Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14217661

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.